News

360Dx1h
Canada's Sepset Biosciences Developing Point-of-Care Sepsis MDx With Eye Toward US Commercialization
The researchers reported in Nature Communications that the PCR-based test and bedside instrument can identify the risk of sepsis within 24 hours.
360Dx3h
Point-of-Care MDx Sepsis Test Being Developed With Plans for US Commercialization
The researchers reported in Nature Communications that the PCR-based test and bedside instrument can identify the risk of sepsis within 24 hours.
360Dx7h
Fujirebio, Stanford Medicine Form Infectious Disease Testing Alliance
The partners will work together to explore the use of a technology from Fujirebio subsidiary Fluxus in infectious disease.
360Dx7h
Randox Laboratories Gains FDA De Novo Clearance for Hemophilia CDx
The Randox ConcizuTrace ELISA is used to determine the concentration in blood of Novo Nordisk's Alhemo (concizumab-mtci) to aid dose adjustments.
360Dx21h
Shifts in Point-of-Care Testing Space Led to Dropping of Savanna System, QuidelOrtho Says
Company officials disclosed that it had been eyeing an out from Savanna in the potential acquisition of Lex Diagnostics for at least the past 18 months.